Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $372.8700 (4.72%) ($372.8700 - $372.8700) on Wed. Feb. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 38 | Latest Price | $372.8700(4.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2% a day on average for past five trading days. | Weekly Trend | REGN declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(41%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.88% in a week (0% probabilities). VIXM(-24%) VXX(-10%) TLT(-5%) IGOV(-5%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $348.88(6.88%) | 10 Day Moving Average | $347.11(7.42%) | 20 Day Moving Average | $362.49(2.86%) | To recent high | -4.6% | To recent low | 14.9% | Market Cap | $39.535b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |